Le Jeune Puetz Investment Counsel LLC Amgen Inc Transaction History

Le Jeune Puetz Investment Counsel LLC

$272 Million
Q1 2023

A detailed history of Le Jeune Puetz Investment Counsel LLC transactions in Amgen Inc stock. As of the latest transaction made, Le Jeune Puetz Investment Counsel LLC holds 15,209 shares of AMGN stock, worth $4.86 Million. This represents 1.35% of its overall portfolio holdings.

Number of Shares

15,209

Previous 15,204 0.03%

Holding current value

$4.86 Million

Previous $3.99 Million 7.94%

% of portfolio

1.35%

Previous 1.53%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$225.79 - $275.2 $1,128 - $1,376	5 Added 0.03%	15,209 $3.68 Million
Q4 2022 Jan 20, 2023	SELL	$229.03 - $291.01 $26,338 - $33,466	-115 Reduced 0.75%	15,204 $0
Q2 2022 Jul 21, 2022	BUY	$230.71 - $256.74 $206,485 - $229,782	895 Added 6.2%	15,319 $3.73 Million
Q1 2022 May 02, 2022	BUY	$219.27 - $242.57 $21,927 - $24,257	100 Added 0.7%	14,424 $3.49 Million
Q4 2021 Jan 31, 2022	BUY	$198.88 - $227.6 $87,507 - $100,144	440 Added 3.17%	14,324 $3.22 Million
Q3 2021 Oct 26, 2021	BUY	$212.27 - $248.7 $149,650 - $175,333	705 Added 5.35%	13,884 $2.95 Million
Q2 2021 Jul 27, 2021	SELL	$233.58 - $259.14 $23,358 - $25,914	-100 Reduced 0.75%	13,179 $3.21 Million
Q1 2021 Apr 26, 2021	BUY	$221.91 - $258.6 $49,929 - $58,185	225 Added 1.72%	13,279 $3.3 Million
Q4 2020 Jan 28, 2021	BUY	$216.38 - $257.67 $24,018 - $28,601	111 Added 0.86%	13,054 $3 Million
Q3 2020 Nov 03, 2020	BUY	$234.65 - $260.95 $11,732 - $13,047	50 Added 0.39%	12,943 $3.29 Million
Q2 2020 Aug 03, 2020	SELL	$197.81 - $242.74 $49,452 - $60,685	-250 Reduced 1.9%	12,893 $3.04 Million
Q1 2020 Apr 29, 2020	SELL	$182.24 - $241.7 $104,241 - $138,252	-572 Reduced 4.17%	13,143 $2.66 Million
Q4 2019 Jan 28, 2020	SELL	$189.21 - $243.2 $37,842 - $48,640	-200 Reduced 1.44%	13,715 $3.31 Million
Q3 2019 Oct 23, 2019	BUY	$174.11 - $208.62 $34,822 - $41,724	200 Added 1.46%	13,915 $2.69 Million
Q2 2019 Jul 29, 2019	BUY	$166.7 - $195.41 $12,502 - $14,655	75 Added 0.55%	13,715 $2.53 Million
Q1 2019 Apr 23, 2019	BUY	$180.87 - $203.88 $136,014 - $153,317	752 Added 5.83%	13,640 $2.59 Million
Q4 2018 Jan 30, 2019	BUY	$178.4 - $208.25 $137,368 - $160,352	770 Added 6.35%	12,888 $2.51 Million
Q2 2018 Jul 26, 2018	SELL	$166.05 - $186.51 $29,058 - $32,639	-175 Reduced 1.42%	12,118 $2.24 Million
Q1 2018 Apr 27, 2018	BUY	$169.43 - $198.0 $16,095 - $18,810	95 Added 0.78%	12,293 $2.1 Million
Q4 2017 Jan 31, 2018	SELL	$168.79 - $188.59 $16,879 - $18,859	-100 Reduced 0.81%	12,198 $2.12 Million
Q3 2017 Oct 20, 2017	BUY	$167.29 - $191.0 $2.06 Million - $2.35 Million	12,298	12,298 $2.29 Million

Others Institutions Holding AMGN

# of Institutions

3,056

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Le Jeune Puetz Investment Counsel LLC, based on Form 13F filings with the SEC.

News

Stay updated on Le Jeune Puetz Investment Counsel LLC with notifications on news.

Account

Le Jeune Puetz Investment Counsel LLC Amgen Inc Transaction History